Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Janet, Dunn"'
Autor:
Joyce Yeung, Shaman Jhanji, John Braun, Janet Dunn, Lucy Eggleston, Samuel Frempong, Louise Hiller, Claire Jacques, Monica Jefford, James Mason, Ramani Moonesinghe, Rupert Pearse, Benjamin Shelley, Cecilia Vindrola, on behalf of VITAL trial team
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Improving outcomes after surgery is a major public health research priority for patients, clinicians and the NHS. The greatest burden of perioperative complications, mortality and healthcare costs lies amongst the population of pa
Externí odkaz:
https://doaj.org/article/e36925d16833409fbbfb0c831d4adb24
Autor:
Jill M. Brooks, Yuanning Zheng, Kelly Hunter, Benjamin E. Willcox, Janet Dunn, Paul Nankivell, Olivier Gevaert, Hisham Mehanna
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe incidence of oropharyngeal cancer (OPC) is increasing, due mainly to a rise in Human Papilloma Virus (HPV)-mediated disease. HPV-mediated OPC has significantly better prognosis compared with HPV-negative OPC, stimulating interest in tre
Externí odkaz:
https://doaj.org/article/f12a3ff832bb48f7a7eb35b9911523e9
Autor:
Karthik Ramasamy, Gulnaz Iqbal, Richard Brouwer, Victoria Stalker, Salma Akhtar, Sherin Varghese, Jindriska Lindsay, Stephen Schey, Mark Drayson, Janet Dunn
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 11, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/08316e6b1c274115a45aa6fcf0930f07
Autor:
Drayson, Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D. Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq Wandroo, Janet Dunn, Mark T.
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3337
Multiple myeloma (MM) patients risk diagnostic delays and irreversible organ damage. In those with newly diagnosed myeloma, we explored the presenting symptoms to identify early signals of MM and their relationships to organ damage. The symptoms were
Autor:
Deborah Fenlon, Adrienne Morgan, Priya Khambaita, Pankaj Mistry, Janet Dunn, Mei-Lin Ah-See, Emma Pennery, Myra S. Hunter, on behalf of the NCRI CSG Breast Cancer Symptom Working Party
Publikováno v:
Journal of Psychosomatic Obstetrics and Gynecology, Vol 38, Iss 4, Pp 276-283 (2017)
Introduction: Menopausal problems are among the most prevalent and distressing problems following breast cancer treatment, with 70% women experiencing hot flushes and night sweats (HFNS). A working party was set up to support the development of new r
Externí odkaz:
https://doaj.org/article/9ea7dadf47fc45768c77998a9acf4869
Autor:
Amit Goyal, Sophie Cramp, Andrea Marshall, Duncan Wheatley, Natalie Hammonds, Shama Puri, Tara Homer, Luke Vale, Roeum Butt, Romaana Mir, Janice Rose, Helen Teresa Edwards, Samreen Ahmed, Abeer Shaaban, Beatrix Elsberger, Julie Bruce, Sophie Gasson, Valerie Speirs, Jacqui Shaw, Helen Higgins, Janet Dunn
Publikováno v:
Cancer Research. 82:OT1-04
Background: For patients who are node positive to start at presentation and are found to have a complete nodal tumour response (ypN0) post neoadjuvant chemotherapy (NACT), we do not yet know whether local axillary therapy can be modified based on the
Autor:
Charles Agbuduwe, Gulnaz Iqbal, David Cairns, Tom Menzies, Janet Dunn, Walter Gregory, Martin Kaiser, Roger Owen, Charlotte Pawlyn, J. Anthony Child, Faith Davies, Gareth J. Morgan, Graham H. Jackson, Mark T. Drayson, Supratik Basu
Immunoglobulin D (IgD) myeloma is a subtype often considered to have adverse features and inferior survival, but there is a paucity of data from large clinical studies. We compare the clinical characteristics and outcomes of patients with IgD myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49fe75b4561cef1c28332680e8a2ed8a
https://eprints.whiterose.ac.uk/189006/1/advancesadv2022007608.pdf
https://eprints.whiterose.ac.uk/189006/1/advancesadv2022007608.pdf
Autor:
Amit Goyal, Shama Puri, Andrea Marshall, Kalliope Valassiadou, Moin Hoosein, Amtul R Carmichael, Gabriella Erdelyi, Nisha Sharma, Janet Dunn, Joanne York
Publikováno v:
Cancer Research. 81:PS1-32
Background: The primary aim of this prospective, multicentre feasibility study was to determine whether the biopsied axillary node in patients with breast cancer can be marked using black carbon dye and successfully identified at the time of surgery.
Autor:
Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Maria del Monte-Millán, Sara López-Tarruella, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Stephen B Edge, Jean E Abraham, John M S Bartlett, Carlos Caldas, Janet Dunn, Helena Earl, Larry Hayward, Louise Hiller, Elena Provenzano, Stephen-John Sammut, Jeremy S Thomas, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela M DeMichele, Kimberly Cole, Lajos Pusztai, Mi-Ok Kim, Laura J van 't Veer, Laura J Esserman, W Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita M. Asare, Ron Balassanian, Heather Beckwith, Scott M. Berry, Donald A. Berry, Judy C. Boughey, Meredith B. Buxton, Yunn-Yi Chen, Beiyun Chen, A. Jo Chien, Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace, Shi Wei, Amy Wilson, Douglas Yee, Jay C. Zeck
Publikováno v:
I-SPY 2 Trial Consortium 2022, ' Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients ', The Lancet Oncology, vol. 23, no. 1, pp. 149-160 . https://doi.org/10.1016/S1470-2045(21)00589-1
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group
Background: Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled patient-level analysis to evaluate the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b5a03d8d05046179f5dcc364471bd0
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
https://research.vumc.nl/en/publications/4b35d135-33e6-4bf5-982e-dab0f5ddbfd8
Autor:
Stephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, Elena Provenzano, Helen A. Bardwell, Wenxin Ma, Wei Cope, Ali Dariush, Sarah-Jane Dawson, Jean E. Abraham, Janet Dunn, Louise Hiller, Jeremy Thomas, David A. Cameron, John M. S. Bartlett, Larry Hayward, Paul D. Pharoah, Florian Markowetz, Oscar M. Rueda, Helena M. Earl, Carlos Caldas
Publikováno v:
Nature
Sammut, S-J, Crispin-Ortuzar, M, Chin, S-F, Provenzano, E, Bardwell, H A, Ma, W, Cope, W, Dariush, A, Dawson, S-J, E. Abraham, J, Dunn, J, Hiller, L, Thomas, J, Cameron, D A, Bartlett, J, Hayward, L, Pharoah, P D, Markowetz, F, Rueda, O M, Earl, H M & Caldas, C 2021, ' Multi-omic machine learning predictor of breast cancer therapy response ', Nature, vol. 601, pp. 623–629 . https://doi.org/10.1038/s41586-021-04278-5
Sammut, S-J, Crispin-Ortuzar, M, Chin, S-F, Provenzano, E, Bardwell, H A, Ma, W, Cope, W, Dariush, A, Dawson, S-J, E. Abraham, J, Dunn, J, Hiller, L, Thomas, J, Cameron, D A, Bartlett, J, Hayward, L, Pharoah, P D, Markowetz, F, Rueda, O M, Earl, H M & Caldas, C 2021, ' Multi-omic machine learning predictor of breast cancer therapy response ', Nature, vol. 601, pp. 623–629 . https://doi.org/10.1038/s41586-021-04278-5
Breast cancers are complex ecosystems of malignant cells and the tumour microenvironment1. The composition of these tumour ecosystems and interactions within them contribute to responses to cytotoxic therapy2. Efforts to build response predictors hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd92c7554a9178110511ee8e2eeecbf